+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Precision Medicine Market Analysis, 2020

  • PDF Icon

    Report

  • 203 Pages
  • October 2020
  • Region: Global
  • MarkNtel Advisors LLP
  • ID: 5447842

Rising Global Cancer Cases Expected to Spur the Growth of the Global Precision Medicine market

Global Precision Medicine Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Precision Medicine market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

Market Opportunities


According to this research report titled “Global Precision Medicine Market Analysis, 2020”, the Global Precision Medicine market is anticipated to grow at a CAGR of around 11% during 2020-25F owing to the factors such as escalating investment by the major pharmaceutical companies in precision medicine, increasing burden of cancer cases, and booming ageing population worldwide. Moreover, technological advancement in wireless technologies and big data analytics, the rising patient inclination toward personalized treatment, and significant strides in the research areas pertaining to precision medicine in the recent years are some of the factors expected to fuel the growth of the market in the coming years. Moreocer, COVID-19 has a positive impact on the Global precison medicine market as it is widely use to accelerate the COVID-19 treatment.

Market Segmentation


Pharmaceutical Companies Are Expected to Attain Highest CAGR

Based on end user, pharmaceutical companies are expected to grow at a highest CAGR during 2020-25 in the Global Precision Medicine market on account of rising incidences of neurological disorders and increasing spending by the giant pharmaceutical companies in the research and development of precision medicine. Moreover, surging government initiatives to improve healthcare and reduction in the overall healthcare costs are projected to drive the growth of the Precision Medicine market globally in the near future as stated in the research report “Global Precision Medicine Market Analysis, 2020”.

Competitive Landscape


According to the publisher, the key players with a considerable market share in the Global Precision Medicine market include Orion Health, 2B Precise, Fabric Genomics, Pfizer, Gene 42, IBM Watson Health, Philips Healthcare, Medtronic, Nanthealth, Navican, N-of-One, PierianDx, Sunquest Information System, Tempus, Novartis, Translational Software, Biocrates Life Sciences AG, anostring Technologies, Thermo Fisher Scientific, Quest Diagnostics Incorporated etc.

Key Questions Answered in the Market Research Report:


1. What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of Global Precision Medicine Market?
2. What is the region wise industry size, growth drivers and challenges key market trends?
3. What are the key innovations, technology upgrades, opportunities, regulations in the Global Precision Medicine Market?
4. Who are the key competitors or market players and how they perform in Global Precision Medicine Market based on competitive benchmarking matrix?
5. What are the key results derived from the market surveys conducted during the course of Global Precision Medicine Market study?

Table of Contents

1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Assumptions
1.4. Market Segmentation
2. Preface3. Executive Summary4. Impact of COVID-19 on Global Precision Medicine Market
5. Global Precision Medicine Market Outlook, 2016-2026F
5.1. Market Size & Analysis
5.1.1. By Revenues
5.2. Market Share & Analysis
5.2.1. By Field of Medicine
5.2.1.1. Applied Sciences
5.2.1.1.1. Genomics
5.2.1.1.1.1. Market Size & Analysis
5.2.1.1.1.1.1. By Revenues
5.2.1.1.1.2. Market Share & Analysis
5.2.1.1.1.2.1. By Technology
5.2.1.1.1.2.1.1. PCR
5.2.1.1.1.2.1.1.1. Consumables Vs Instruments
5.2.1.1.1.2.1.1.2. Diagnostic Companies Vs Biopharma Companies Vs Others
5.2.1.1.1.2.1.1.3. North America Vs Europe Vs APAC Vs South America Vs MEA
5.2.1.1.1.2.1.2. Next Generation Sequencing
5.2.1.1.1.2.1.2.1. Sample & Library Preparation Vs Sequencing Vs Target Enrichment Vs Instruments Vs Consumables
5.2.1.1.1.2.1.2.2. Sequencing By Synthesis Vs Single Molecule Real Time Sequencing Vs Nanopore Technologies Vs Others
5.2.1.1.1.2.1.2.3. North America Vs Europe Vs APAC Vs South America Vs MEA
5.2.1.1.1.2.1.3. Genome Editing
5.2.1.1.1.2.1.3.1. Editing Kits Vs Services Vs Cell Lime Models
5.2.1.1.1.2.1.3.2. Research Organizations Vs Pharma & Biotech Companies Vs Other
5.2.1.1.1.2.1.3.3. North America Vs Europe Vs APAC Vs South America Vs MEA
5.2.1.1.1.2.1.4. Others
5.2.1.1.2. Pharmacogenics
5.2.1.1.2.1. Global Precision Medicine Genomics Market, 2016-2026F
5.2.1.1.2.2. Market Size & Analysis
5.2.1.1.2.2.1. By Revenues
5.2.1.1.2.3. Market Share & Analysis
5.2.1.1.2.3.1. By Services
5.2.1.1.2.3.1.1. Genotyping
5.2.1.1.2.3.1.2. SNP Identification
5.2.1.1.2.3.1.3. Diagnostics
5.2.1.1.2.3.1.4. Others
5.2.1.1.2.3.2. By End Users
5.2.1.1.2.3.2.1. Research Organizations
5.2.1.1.2.3.2.2. Pharma Companies
5.2.1.1.2.3.2.3. Diagnostics Companies
5.2.1.1.2.3.3. By Region
5.2.1.1.2.3.3.1. North America
5.2.1.1.2.3.3.2. South America
5.2.1.1.2.3.3.3. Europe
5.2.1.1.2.3.3.4. MEA
5.2.1.1.2.3.3.5. APAC
5.2.1.1.3. Others
5.2.1.2. Precision Diagnostics
5.2.1.2.1. Global Precision Diagnostics Market Outlook, 2016-2026F
5.2.1.2.1.1. Market Size & Analysis
5.2.1.2.1.1.1. By Revenues
5.2.1.2.1.2. Market Share & Analysis
5.2.1.2.1.2.1. By Type
5.2.1.2.1.2.1.1. Molecular Diagnostics
5.2.1.2.1.2.1.1.1. By Type (NIPT, Companion Diagnostics, Liquid Biopsy, Others)
5.2.1.2.1.2.1.1.2. By Region
5.2.1.2.1.2.1.2. Medical Imaging
5.2.1.2.1.2.1.2.1. By Type (Imaging CAD Vs Image Analytics)
5.2.1.2.1.2.1.2.2. By Region
5.2.1.3. Digital Health & Information Technology
5.2.1.3.1. Global Digital Health & Information Technology Market Outlook, 2016-2026F
5.2.1.3.1.1. Market Size & Analysis
5.2.1.3.1.1.1. By Revenues
5.2.1.3.1.2. Market Share & Analysis
5.2.1.3.1.2.1. By Type
5.2.1.3.1.2.1.1. CDSS
5.2.1.3.1.2.1.2. Big Data Analytics
5.2.1.3.1.2.1.3. IT Infrastructure
5.2.1.3.1.2.1.4. Genomics Informatics
5.2.1.3.1.2.1.4.1. Data Analytics
5.2.1.3.1.2.1.4.2. System Integration Software
5.2.1.3.1.2.1.4.3. Data Management Software
5.2.1.3.1.2.1.4.4. Reporting & Interpretation Software
5.2.1.3.1.2.1.4.5. Workflow Management Software
5.2.1.3.1.2.1.4.6. LIMS
5.2.1.3.1.2.1.5. In-Silico Informatics
5.2.1.3.1.2.1.6. Mobile Health
5.2.1.3.1.2.2. By End Users
5.2.1.3.1.2.2.1. Research Organizations
5.2.1.3.1.2.2.2. Diagnostic Companies
5.2.1.3.1.2.2.3. Biopharmaceutical Companies
5.2.1.3.1.2.3. By Region
5.2.1.3.1.2.3.1. North America
5.2.1.3.1.2.3.2. South America
5.2.1.3.1.2.3.3. Europe
5.2.1.3.1.2.3.4. APAC
5.2.1.3.1.2.3.5. MEA
5.2.1.4. Precision Therapeutics
5.2.1.4.1. Global Precision Therapeutics Market Outlook, 2016-2026F
5.2.1.4.1.1. Market Size & Analysis
5.2.1.4.1.1.1. By Revenues
5.2.1.4.1.2. Market Share & Analysis
5.2.1.4.1.2.1. By Type
5.2.1.4.1.2.1.1. Clinical Trials
5.2.1.4.1.2.1.2. Cell Therapy
5.2.1.4.1.2.1.3. Drug Discovery & Research
5.2.1.4.1.2.1.4. Gene Therapy
5.2.1.4.1.2.2. By Region
5.2.1.4.1.2.2.1. North America
5.2.1.4.1.2.2.2. South America
5.2.1.4.1.2.2.3. Europe
5.2.1.4.1.2.2.4. APAC
5.2.1.4.1.2.2.5. MEA
5.2.2. By Application
5.2.2.1. Oncology
5.2.2.2. Infectious Disease
5.2.2.3. Neurology
5.2.2.4. Cardiology
5.2.2.5. Lifestyle & Endocrinology
5.2.2.6. Gastroenterology
5.2.2.7. Others
5.2.3. By Region
5.2.3.1. North America
5.2.3.2. South America
5.2.3.3. Europe
5.2.3.4. APAC
5.2.3.5. MEA
5.2.4. By Competitors
5.2.4.1. Competition Characteristics
5.2.4.2. Market Share
5.2.4.3. Competition Quadrant
6. North America Precision Medicine Market Outlook, 2016-2026F
6.1. Market Size & Analysis
6.1.1. By Revenues
6.2. Market Share & Analysis
6.2.1. By Field of Medicine
6.2.1.1. Applied Sciences
6.2.1.2. Precision Diagnostics
6.2.1.3. Digital Health & IT
6.2.1.4. Precision Therapeutics
6.2.2. By Country
6.2.2.1. The US Precision Medicine Market Outlook, 2016-2026F (USD Million)
6.2.2.2. Canada Precision Medicine Market Outlook, 2016-2026F (USD Million)
6.2.2.3. Mexico Precision Medicine Market Outlook, 2016-2026F (USD Million)
7. Europe Precision Medicine Market Outlook, 2016-2026F
7.1. Market Size & Analysis
7.1.1. By Revenues
7.2. Market Share & Analysis
7.2.1. By Field of Medicine
7.2.1.1. Applied Sciences
7.2.1.2. Precision Diagnostics
7.2.1.3. Digital Health & IT
7.2.1.4. Precision Therapeutics
7.2.2. By Country
7.2.2.1. Germany Precision Medicine Market Outlook, 2016-2026F (USD Million)
7.2.2.2. France Precision Medicine Market Outlook, 2016-2026F (USD Million)
7.2.2.3. The UK Precision Medicine Market Outlook, 2016-2026F (USD Million)
7.2.2.4. Spain Precision Medicine Market Outlook, 2016-2026F (USD Million)
7.2.2.5. Italy Precision Medicine Market Outlook, 2016-2026F (USD Million)
7.2.2.6. Scandinavia Precision Medicine Market Outlook, 2016-2026F (USD Million)
8. South America Precision Medicine Market Outlook, 2016-2026F
8.1. Market Size & Analysis
8.1.1. By Revenues
8.2. Market Share & Analysis
8.2.1. By Field of Medicine
8.2.1.1. Applied Sciences
8.2.1.2. Precision Diagnostics
8.2.1.3. Digital Health & IT
8.2.1.4. Precision Therapeutics
8.2.2. By Country
8.2.2.1. Brazil Precision Medicine Market Outlook, 2016-2026F (USD Million)
9. Asia Pacific (APAC) Precision Medicine Market Outlook, 2016-2026F
9.1. Market Size & Analysis
9.1.1. By Revenues
9.2. Market Share & Analysis
9.2.1. By Field of Medicine
9.2.1.1. Applied Sciences
9.2.1.2. Precision Diagnostics
9.2.1.3. Digital Health & IT
9.2.1.4. Precision Therapeutics
9.2.2. By Country
9.2.2.1. China Precision Medicine Market Outlook, 2016-2026F (USD Million)
9.2.2.2. India Precision Medicine Market Outlook, 2016-2026F (USD Million)
9.2.2.3. Japan Precision Medicine Market Outlook, 2016-2026F (USD Million)
9.2.2.4. Australia Precision Medicine Market Outlook, 2016-2026F (USD Million)
9.2.2.5. South Korea Precision Medicine Market Outlook, 2016-2026F (USD Million)
10. Middle East & Africa Precision Medicine Market Outlook, 2016-2026F
10.1. Market Size & Analysis
10.1.1. By Revenues
10.2. Market Share & Analysis
10.2.1. By Field of Medicine
10.2.1.1. Applied Sciences
10.2.1.2. Precision Diagnostics
10.2.1.3. Digital Health & IT
10.2.1.4. Precision Therapeutics
10.2.2. By Country
10.2.2.1. UAE Precision Medicine Market Outlook, 2016-2026F (USD Million)
10.2.2.2. Saudi Arabia Precision Medicine Market Outlook, 2016-2026F (USD Million)
10.2.2.3. South Africa Precision Medicine Market Outlook, 2016-2026F (USD Million)
11. Global Precision Medicine Policies & Regulations
11.1. By Region
11.1.1. The United States
11.1.2. European Union
12. Global Precision Medicine Trends & Insights, 2020
13. Global Precision Medicine Market Dynamics
13.1. Drivers
13.2. Challenges
13.3. Impact Analysis
14. Global Precision Medicine Market Hotspot & Opportunities15. Global Precision Medicine Market Patents & Intellectual Property Analysis
16. Global Precision Medicine Market Competition Outlook
16.1. Competition Outlook
16.1.1. Brand Specialization
16.1.2. Target Markets
16.1.3. Target Applications
16.1.4. Research & Development
16.1.5. Collaborations & Strategic Alliances
16.1.6. Key Business Expansion Initiatives
16.1.7. Business Restructuring- Mergers, Acquisitions, JVs
16.1.8. Strategic Initiatives
16.2. Company Profiles (Business Description, Product Offering, Strategic Alliances or Partnerships, etc.)
16.2.1. ThermoFisher Scientific
16.2.2. Abbott Laboratories
16.2.3. Almac Group Ltd.
16.2.4. Amgen Inc
16.2.5. Angle PLC
16.2.6. Astellas Pharma Inc.
16.2.7. AstraZeneca
16.2.8. ASURAGEN INC.
16.2.9. Bio-Rad Laboratories, Inc.
16.2.10. bioMérieux S.A.
16.2.11. Bristol-Myers Squibb Company
16.2.12. Cardiff Oncology
16.2.13. CETICS Healthcare Technologies GmbH
16.2.14. Danaher Corporation
16.2.15. Eli Lilly and Company Limited
16.2.16. Epic Sciences, Inc.
16.2.17. F. Hoffmann-La Roche Ltd
16.2.18. Gilead Sciences, Inc.
16.2.19. GlaxoSmithKline plc
16.2.20. Illumina, Inc.
16.2.21. Intomics A/S
16.2.22. Johnson & Johnson Services, Inc.
16.2.23. Laboratory Corporation of America Holdings
16.2.24. MDx Health, Inc.
16.2.25. Sanofi S.A.
16.2.26. Sysmex Corporation
16.2.27. Quest Diagnostics Inc
16.2.28. Pfizer Inc.
16.2.29. Novartis AG
16.2.30. Merck KGaA
17. Disclaimer

Companies Mentioned

  • Orion Health
  • 2B Precise
  • Fabric Genomics
  • Pfizer
  • Gene 42
  • IBM Watson Health
  • Philips Healthcare
  • Medtronic
  • Nanthealth
  • Navican
  • N-of-One
  • PierianDx
  • Sunquest Information System
  • Tempus
  • Novartis
  • Translational Software
  • Biocrates Life Sciences AG
  • anostring Technologies
  • Thermo Fisher Scientific
  • Quest Diagnostics Incorporated

Methodology

Loading
LOADING...